Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
67%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Completed1
Withdrawn1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

completed133%
withdrawn133%
enrolling_by_invitation133%

Recent Activity

0 active trials
Showing 3 of 3
enrolling_by_invitationnot_applicable

Prolonged Air Leak (PAL) Autologous Blood Patch Intervention Trial

NCT04954625
withdrawnnot_applicable

Autologous Blood Patch for Primary Spontaneous Pneumothorax

NCT06088901
completed

Effectiveness of the Autologous Blood Patch Method in Lung Biopsies

NCT05904574

Clinical Trials (3)

Showing 3 of 3 trials
NCT04954625Not Applicable

Prolonged Air Leak (PAL) Autologous Blood Patch Intervention Trial

Enrolling By Invitation
NCT06088901Not Applicable

Autologous Blood Patch for Primary Spontaneous Pneumothorax

Withdrawn
NCT05904574

Effectiveness of the Autologous Blood Patch Method in Lung Biopsies

Completed

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3